2023 annual financial data

ACADIA Pharmaceuticals 2023 Operating margin

ACADIA Pharmaceuticals 2023 operating margin with verified reported values.

Direct answer

Operating margin was -10.1%.

Operating income was -73,379,000 USD and net income was -61,286,000 USD.
Operating cash flow was 16,702,000 USD.

Get free ACADIA Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
726,437,000 USD
Operating income
-73,379,000 USD
Net income
-61,286,000 USD
Operating cash flow
16,702,000 USD